文献速递前列腺癌

多参数磁共振在前列腺癌诊疗中应用的标准操作流程更新

Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer.
PubMed 文献 · J Urol · 2019-10-23

本文更新了前列腺磁共振成像的标准操作流程,由美国泌尿外科学会与腹部放射学会专家小组评估文献后制定。推荐所有无活检史男性在前列腺穿刺前进行磁共振检查,并支持用于既往穿刺阴性但风险持续升高的男性;证据尚不足以推荐用于筛查、分期或监测。

要点

  • 推荐无活检史男性在穿刺前进行前列腺磁共振检查
  • 支持用于既往标准穿刺阴性但PSA升高的男性
  • 证据不足以推荐磁共振用于筛查、分期或监测

核心结论

  • 当前证据支持对无活检史且存在前列腺癌风险的男性在穿刺前使用前列腺磁共振。
  • 对初次标准穿刺阴性后PSA升高的男性,磁共振检查也获得证据支持。

研究设计与样本

  • 美国泌尿外科学会与腹部放射学会组成专家小组,评估已发表文献后制定推荐。
  • 有足够研究数据时基于数据推荐,数据不足时基于专家共识推荐。

主要发现

  • 前列腺磁共振应按技术规范和标准进行,并按标准报告解读。
  • 数据支持用于既往穿刺阴性且持续担忧前列腺癌风险增加的男性。
  • 目前证据不足以推荐磁共振用于前列腺癌的筛查、分期或监测。

关键数值与推荐

  • 推荐所有无活检史男性在前列腺穿刺前进行磁共振成像。

临床怎么用

  • 对无活检史男性,可在穿刺前安排前列腺磁共振以辅助诊断。
  • 对既往标准穿刺阴性但PSA升高的男性,可考虑磁共振检查。
  • 不推荐将磁共振常规用于前列腺癌筛查、分期或监测。

局限性

  • 证据不足以推荐磁共振用于筛查、分期或监测。
  • 部分推荐基于专家共识而非充分研究数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We update the prior standard operating procedure for magnetic resonance imaging of the prostate, and summarize the available data about the technique and clinical use for the diagnosis and management of prostate cancer. This update includes practical recommendations on the use of magnetic resonance imaging for screening, diagnosis, staging, treatment and surveillance of prostate cancer. MATERIALS AND METHODS: A panel of clinicians from the American Urological Association and Society of Abdominal Radiology with expertise in the diagnosis and management of prostate cancer evaluated the current published literature on the use and technique of magnetic resonance imaging for this disease. When adequate studies were available for analysis, recommendations were made on the basis of data and when adequate studies were not available, recommendations were made on the basis of expert consensus. RESULTS: Prostate magnetic resonance imaging should be performed according to technical specifications and standards, and interpreted according to standard reporting. Data support its use in men with a previous negative biopsy and ongoing concerns about increased risk of prostate cancer. Sufficient data now exist to support the recommendation of magnetic resonance imaging before prostate biopsy in all men who have no history of biopsy. Currently, the evidence is insufficient to recommend magnetic resonance imaging for screening, staging or surveillance of prostate cancer. CONCLUSIONS: Use of prostate magnetic resonance imaging in the risk stratification, diagnosis and treatment pathway of men with prostate cancer is expanding. When quality prostate imaging is obtained, current evidence now supports its use in men at risk of harboring prostate cancer and who have not undergone a previous biopsy, as well as in men with an increasing prostate specific antigen following an initial negative standard prostate biopsy procedure.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Bjurlin MA, Carroll PR, Eggener S, et al. Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer. J Urol. 2019. PMID: 31642740. doi:10.1097/JU.0000000000000617

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。